MOLN
Molecular Partners·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MOLN fundamentals
Molecular Partners (MOLN) released its earnings on Oct 30, 2025: revenue was 0 (YoY -100.00%), beat estimates; EPS was -0.4 (YoY +31.07%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.4
+31.07%
Report date
Oct 30, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Molecular Partners (MOLN) key financial stats and ratios, covering profitability, financial health, and leverage.
Molecular Partners (MOLN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Molecular Partners (MOLN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Molecular Partners (MOLN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Molecular Partners (MOLN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Molecular Partners (MOLN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Molecular Partners's gross profit margin?Did Molecular Partners beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Molecular Partners year over year?What is Molecular Partners's latest dividend and current dividend yield?What were the key takeaways from Molecular Partners’s earnings call?What does Molecular Partners do and what are its main business segments?What factors drove the changes in Molecular Partners's revenue and profit?What were the key takeaways from Molecular Partners's earnings call?
